Board member Eric Schmidt resigns; Lorence Kim named Audit Committee Chair

Revolution Medicines, Inc.

Eric T. Schmidt resigned from Board and Audit Committee, effective Sept 5, 2023, to become an investment analyst.
Resignation was not due to any disagreement with Revolution Medicines.
Lorence Kim appointed Chair of Audit Committee; Alexis Borisy appointed to Audit Committee to fill vacancy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Eric T. Schmidt

Director

RVMD · Revolution Medicines, Inc.

Effective: 2023-09-05
Filed: September 5, 2023, 7:59 PM ET

On August 31, 2023, Eric T. Schmidt, Ph.D., resigned from the Board of Directors (the “Board”) of Revolution Medicines, Inc. (the “Company”), effective September 5, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eric T. Schmidt resigned as Director at Revolution Medicines, Inc..

Action: resigned
Role: Director

Exact text from the filing

On August 31, 2023, Eric T. Schmidt, Ph.D., resigned from the Board of Directors (the “Board”) of Revolution Medicines, Inc. (the “Company”), effective September 5, 2023.

View on SEC.gov

Revolution Medicines, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-228515

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.